We are focused on the investigation and advancement of diabetes therapies. Our current research is dedicated to addressing type 1 diabetes.
Aims to provide a long-term auto-regulation therapeutic solution. Our technology is made from material approved in other FDA approved medical devices, and has undergone small animal proof of concept studies.
Our proprietary technology will be loaded glucose responsive insulin secreting cells, and implanted under the skin. Once inside the device cells will be protected from the immune system but still able to maintain nutrient exchange to respond to their environment.
Our ultra thin-film membranes (top), have been used to create our thin and flexible device (center left), and implanted in animals (center right) to demonstrate allo protection in vivo at 30, 60, 90 days (bottom).